Fig. 3 | Scientific Reports

Fig. 3

From: Integrating bulk and single cell sequencing data to identify prognostic biomarkers and drug candidates in HBV associated hepatocellular carcinoma

Fig. 3

Validation the predictive performance of the immune risk index. (A, B) ROC curves of 1-year, 3-year, and 5-year OS in the training TCGA-LIHC (A) and test ICGC-LIRI-JP datasets (B). (C) Heatmap is presented to display the relationship of immune risk groups and clinical features, as well as the expression of the 14 most valuable HBV-HCC related immune genes in patients with HCC. (D-F) Kaplan-Meier survival curve predicted the survival probability for DSS (D), PFI (E) and DFI (F).

Back to article page